SCHEMBL4431768

SCHEMBL4431768

CCOC(=O)ON1CCc2sccc2C(OC)C1

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HHAT Q5VTY9 5/20 0.38
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LHCGR P22888 2/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4430893 0.86 HHAT (0.38) HHATKDM4EALDH1A1LHCGRPOLB
SCHEMBL2992670 0.82 BRD4 (0.43) HHATKDM4EALDH1A1NPSR1BRD4
SCHEMBL2992674 0.82 BRD4 (0.43) HHATKDM4EALDH1A1NPSR1BRD4
SCHEMBL2992673 0.82 BRD4 (0.43) HHATKDM4EALDH1A1NPSR1BRD4
SCHEMBL3302731 0.74 HHAT (0.44) HHATLHCGRPOLBMAPK1NPSR1
SCHEMBL3302736 0.74 HHAT (0.44) HHATLHCGRPOLBMAPK1NPSR1
SCHEMBL4749248 0.74 HHAT (0.44) HHATLHCGRPOLBMAPK1NPSR1
SCHEMBL4440748 0.72 NOS3 (0.35) KDM4EALDH1A1POLBMAPK1
SCHEMBL4751245 0.71 DRD2 (0.40) HHATLHCGRPOLBMAPK1NPSR1
SCHEMBL3304815 0.71 DRD2 (0.40) HHATLHCGRPOLBMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132193-B1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS BOEHRINGER INGELHEIM INT (DE) 2012-10-24 EP disclosed
EP-2132193-A1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS Boehringer Ingelheim International GmbH (DE) 2009-12-16 EP disclosed
WO-2008116881-A1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-10-02 WO disclosed